​​​​​​​How To Select the Right FOA for Fall 2017 Human Subjects Grant Applications | NCCIH

​​​​​​​How To Select the Right FOA for Fall 2017 Human Subjects Grant Applications | NCCIH

How to Prevent Your Fall 2017 Human Subjects Grant Application From Being Withdrawn September 20, 2017 Wendy Weber, N.D., Ph.D., M.P.H., Chief, NCCIH Clinical Research in Complementary and Integrative Health Branch If you are planning to submit a grant application that includes human subjects to NCCIH this fall, we want to help you select the best funding opportunity announcement (FOA) to use.    In a March 2017 NIH Guide Notice (NOT-AT-17-006) and through blog posts, webinars, and direct letters, NCCIH announced changes regarding the types of applications NCCIH will accept via the NIH Parent FOAs. Background: As of May 2017, NCCIH no longer accepts applications that include a study that meets the NIH definition of a clinical trial with aims focused on clinical outcomes if they are submitted through the generic NIH Parent FOAs (R01, R21, R15). Instead, applications that include clinical outcome focused trials need to be submitted to NCCIH via our new clinical trial specific FOAs (https://nccih.nih.gov/grants/funding/clinicaltrials).  This policy is valid for new, resubmission, and renewal applications. Only clinical trials with a focus on mechanistic outcomes may still be submitted  through the generic NIH Parent FOAs.  If you use the Parent FOAs and include a clinical-outcome-focused-trial in your Fall 2017 application, NCCIH will not accept assignment of the application. The Division of Receipt and Referral at NIH will try to find another Institute or Center (IC) to accept your application, but it must fit with the IC’s mission and the ICs must accept clinical trials via these Parent FOAs. If NIH cannot find an IC willing to accept your application, it will be withdrawn and returned to your institution without being reviewed.  Let’s prevent this from happening!

Read the full blog post